GSK Nigeria proposes N0.75 dividend, one new share for shareholders

GlaxoSmithKline Consumer Nigeria said on Thursday it’s 2014 pretax profit fell 36.2 percent to N2.75 billion ($14 million).

The drugmaker’s revenue rose to 30.52 billion naira from 29.18 billion in the same period, it said in a statement.

The company has proposed a dividend of 0.75 naira per share and one new share for every four existing shares to shareholders, unchanged from the previous year.